The CAS Anti-Doping Division issues decisions in the cases of Gabriel Sincraian (ROM/Weightlifting -85kg) and Misha Aloi (RUS/Boxing -52KG)

published on 09 December 2016

Press Release

8 December 2016 - The Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) has issued decisions in two cases related to the Rio 2016 Olympic Games:

Romanian weightlifter Gabriel Sincraian is found to have committed an anti-doping rule violation after testing positive for exogenous Testosterone, a non-specified substance prohibited under S1.1b on the WADA prohibited list, during an in-competition doping control on 12 August 2016.

All results obtained by Gabriel Sincraian in the Rio 2016 Olympic Games, including the bronze medal in the Men’s Weightlifting 85kg event, are disqualified.

Russian boxer Misha Aloian is found to have committed an anti-doping rule violation after testing positive for Tuaminoheptane, a specified stimulant, prohibited in-competition under S6 on the WADA Prohibited List, during an in-competition doping control on 21 August 2016.

The results obtained by the athlete in the Rio 2016 Olympic Games, including the silver medal obtained in the Men’s -52kg boxing event on 21 August 2016, are disqualified.

The Awards will be published on the CAS website: www.tas-cas.org.

Views

2901

Related Articles

Leave a comment

Please login to leave a comment.

Official partners 

BASL
Soccerex Core Logo
SLA LOGO 1kpx
YRDA Logo2
SAC logo LawAccord

Copyright © LawInSport Limited 2010 - 2018. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.